We offer a robust, compassionate, and effective Patient Navigation Program, ensuring much-needed support and care to lung cancer patients. Since 2022, we have reached over 39,000 patients across India and neighboring countries. With nearly 44 lakh social media views, we have emerged as the largest and most impactful lung cancer support community in India, providing comprehensive and free assistance to those in need.
Join our support groups to connect with others, share experiences, and find strength in our community
Navigating the complexities of lung cancer treatment can be overwhelming, which is why our buddy program plays a crucial role in the patient care experience. A buddy is a steadfast virtual companion who assists patients in managing the list of tasks that accompany treatment.
Access a wealth of information to understand your condition and explore treatment options.
Discover various financial assistance programs designed to help manage treatment costs.
Get help with the logistics of your treatment journey, including medicine delivery, finding affordable accommodation while seeking treatment, accessing subsidised food coupons in cities, ensuring a smoother care experience.
We offer palliative and emotional counseling services to provide a safe space for expressing feelings and to offer the support needed during challenging times.
Stay informed about the latest advancements in lung disease treatments.
Gain in-depth knowledge about lung diseases, their symptoms, & effective management strategies.
We believe in the power of advocacy to drive change. We are committed to advocating for policies that make a real difference in the lives of lung cancer patients.
Lung cancer carries a heavy stigma, often unfairly associated solely with smokers. We address this issue by promoting a more compassionate and informed perspective. We bring focus to non-smoking causes of lung cancer emphasizing the importance of broader awareness and earlier detection strategies for all individuals facing this disease.
We connect patients nearing the end of life in villages and rural India to local palliative care centers, helping them to die pain-free and with dignity.
Through our advocacy efforts, cancer has been listed as a notifiable disease in the state of Jharkhand, India. Additionally, economically vulnerable patients in Jharkhand can now receive ₹10 lakhs for their lung cancer treatment.
Our commitment to research is unwavering. We strive to advance the understanding and treatment of lung diseases by supporting research and clinical trials. We bring information of ground-breaking treatment options and research available to patients so that they are aware of the new directions in treatment. We focus on the following key areas:
We are dedicated to supporting research focused on gathering and analyzing comprehensive data to improve our understanding of lung diseases. By collecting high-quality data from diverse populations, we aim to identify patterns, uncover risk factors, and inform the development of targeted treatment strategies. Our data collection efforts enable us to participate in decisions and drive meaningful advancements in respiratory health.
Some of our research prioritizes the needs and outcomes of patients. We design and conduct studies that place patients at the center of our efforts. By involving patients in the research process, we ensure that our studies address their concerns, improve their quality of life, and deliver tangible benefits. Our patient-centric approach fosters collaboration and empowers patients to play an active role in shaping the future of lung disease treatment.
Clinical trials offer significant benefits for patients, enhance therapeutic regimens, and advance evidence-based medical practice. However, accessing data from various trials can be challenging. To address this, the Clinical Trials Registry-India (CTRI), hosted by the ICMR’s National Institute of Medical Statistics, provides a free online public record system for registering clinical trials in India. Patients interested in clinical trials can access comprehensive records through the CTRI, empowering them to make informed treatment decisions.
